ArticleNanomaterials (Basel, Switzerland)2023
Crystalline Mesoporous F-Doped Tin Dioxide Nanomaterial Successfully Prepared via a One Pot Synthesis at Room Temperature and Ambient Pressure.
Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
Abstract
We report the successful one pot synthesis of crystalline mesoporous tin dioxide powder doped with fluoride at ambient pressure and temperature. This material possesses a high surface area, narrow pore size distribution, small average crystallite sizes, and good opto-electrical properties. The existence of fluorine increased the opto-electronic activity of tin dioxide by 20 times, and conductivity by 100 times compared with pristine tin dioxide prepared via the same method. The conductivity of SnO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.